| # | Drug | Count |
|---|---|---|
| 0 | CYCLOPHOSPHAMIDE | 3 |
| 1 | CYCLOPHOSPHAMIDE FOR INJECTION | 3 |
| 2 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 3 |
| 3 | DEXAMETHASONE | 2 |
| 4 | DEXAMETHASONE 1.5 MG | 2 |
| 5 | MYCOPHENOLATE MOFETIL | 2 |
| 6 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 2 |
| 7 | TACROLIMUS | 2 |
| 8 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 2 |
| 9 | TACROLIMUS OINTMENT 0.1% | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | EXAGAMGLOGENE AUTOTEMCEL | 1 | 0.0200 |
| 1 | ERYTHROPOIETIN | 1 | 0.0000 |
| 2 | MELPHALAN HYDROCHLORIDE | 1 | 0.0000 |
| 3 | CARFILZOMIB | 1 | 0.0000 |
| 4 | FILGRASTIM | 1 | 0.0000 |
| 5 | CYCLOPHOSPHAMIDE FOR INJECTION | 3 | 0.0000 |
| 6 | CYCLOPHOSPHAMIDE | 3 | 0.0000 |
| 7 | TACROLIMUS OINTMENT 0.1% | 2 | 0.0000 |
| 8 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 2 | 0.0000 |
| 9 | MYCOPHENOLATE MOFETIL | 2 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | Alkylating Drug [EPC] | 3 |
| 1 | Corticosteroid [EPC] | 2 |
| 2 | Interleukin-6 Receptor Antagonist [EPC] | 1 |
| 3 | Leukocyte Growth Factor [EPC] | 1 |
| 4 | Platinum-based Drug [EPC] | 1 |
| 5 | Proteasome Inhibitor [EPC] | 1 |
| 6 | Thalidomide Analog [EPC] | 1 |
| 7 | Topoisomerase Inhibitor [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Topoisomerase Inhibitor [EPC] | 1 | 0.0000 |
| 1 | Alkylating Drug [EPC] | 3 | 0.0000 |
| 2 | Proteasome Inhibitor [EPC] | 1 | 0.0000 |
| 3 | Interleukin-6 Receptor Antagonist [EPC] | 1 | 0.0000 |
| 4 | Leukocyte Growth Factor [EPC] | 1 | 0.0000 |
| 5 | Platinum-based Drug [EPC] | 1 | 0.0000 |
| 6 | Thalidomide Analog [EPC] | 1 | 0.0000 |
| 7 | Corticosteroid [EPC] | 2 | 0.0000 |